NASDAQ
SWTX

SpringWorks Therapeutics Inc

(NO DISGNOSTIC SUBSTANCES)
LIFE SCIENCES

Prices are adjusted according to historical splits.

SpringWorks Therapeutics Inc Stock Price

Vitals

Today's Low:
$22.8400
Today's High:
$24.6700
Open Price:
$23.9400
52W Low:
$13.6
52W High:
$77.7
Prev. Close:
$24.2600
Volume:
701540

Company Statistics

Market Cap.:
$1.450 billion
Book Value:
6.63
Revenue TTM:
$0.035 billion
Operating Margin TTM:
0%
Gross Profit TTM:
$0.035 billion
Gross Profit TTM:
$0.035 billion
Profit Margin:
0%
Return on Assets TTM:
-32%
Return on Equity TTM:
-55.4%

Company Profile

SpringWorks Therapeutics Inc had its IPO on 2019-09-13 under the ticker symbol SWTX.

The company operates in the LIFE SCIENCES sector and (NO DISGNOSTIC SUBSTANCES) industry. SpringWorks Therapeutics Inc has a staff strength of 0 employees.

Stock update

Shares of SpringWorks Therapeutics Inc opened at $23.94 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $22.84 - $24.67, and closed at $23.24.

This is a -4.2% slip from the previous day's closing price.

A total volume of 701,540 shares were traded at the close of the day’s session.

In the last one week, shares of SpringWorks Therapeutics Inc have slipped by -7.04%.

SpringWorks Therapeutics Inc's Key Ratios

SpringWorks Therapeutics Inc has a market cap of $1.450 billion, indicating a price to book ratio of 4.858 and a price to sales ratio of 74.5.

In the last 12-months SpringWorks Therapeutics Inc’s revenue was $0.035 billion with a gross profit of $0.035 billion and an EBITDA of $-0.227 billion. The EBITDA ratio measures SpringWorks Therapeutics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SpringWorks Therapeutics Inc’s operating margin was 0% while its return on assets stood at -32% with a return of equity of -55.4%.

In Q2, SpringWorks Therapeutics Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

SpringWorks Therapeutics Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-4.231 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SpringWorks Therapeutics Inc’s profitability.

SpringWorks Therapeutics Inc stock is trading at a EV to sales ratio of 64.18 and a EV to EBITDA ratio of -5.53. Its price to sales ratio in the trailing 12-months stood at 74.5.

SpringWorks Therapeutics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

SpringWorks Therapeutics Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

SpringWorks Therapeutics Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

SpringWorks Therapeutics Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, SpringWorks Therapeutics Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, SpringWorks Therapeutics Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$23.24
52-Week High
$77.7
52-Week Low
$13.6
Analyst Target Price
$78.2

SpringWorks Therapeutics Inc stock is currently trading at $23.24 per share. It touched a 52-week high of $77.7 and a 52-week low of $77.7. Analysts tracking the stock have a 12-month average target price of $78.2.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About SpringWorks Therapeutics Inc

The stock symbol (also called stock or share ticker) of SpringWorks Therapeutics Inc is SWTX

The IPO of SpringWorks Therapeutics Inc took place on 2019-09-13

Similar Industry Stocks ((NO DISGNOSTIC SUBSTANCES))

Last Price
Chg
Chg%
$2.97
-0.12
-3.88%
$2.05
-0.01
-0.49%
$0.41
0
+0.75%
Moderna Inc (MRNA)
$148.62
-6
-3.88%
$0.67
-0.05
-7.2%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
$0.02
0.01
+100%
Oi S.A (OIBR-C)
$0
0
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

SpringWorks Therapeutics, Inc. acquires, develops and markets drugs for underserved patient populations suffering from rare diseases and cancer. The company is headquartered in Stamford, Connecticut.

Address

100 WASHINGTON BOULEVARD, STAMFORD, CT, US